Carregando...
What next for newly diagnosed glioblastoma?
Glioblastoma is the most common primary brain tumor in adults. Despite current multimodality treatment including surgical resection and temozolomide-based chemoradiotherapy, median survival is only 14–16 months. Characterization of molecular alterations in glioblastoma has identified prognostic subg...
Na minha lista:
| Publicado no: | Future Oncol |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4976851/ https://ncbi.nlm.nih.gov/pubmed/26558493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.15.258 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|